WASHINGTON (AP) — A smirking Martin Shkreli briefly united Democrats and Republicans on Capitol Hill this week, as lawmakers took turns blasting the price-hiking former CEO who has become the new poster child for corporate greed. But the gridlocked state of Congress virtually assures federal efforts to lower drug prices will remain in limbo for years.Read more on NewsOK.com